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BaCkgrounD: Approximately 26% of Canadians living with HIV 
are unaware of their status. Point-of-care (POC) HIV tests have been 
introduced to simplify and expand HIV testing. 
oBJeCTIVe: To evaluate the feasibility and acceptability of POC test-
ing in an emergency department (ED) setting in Winnipeg, Manitoba.
MeTHoDs: A cross-sectional study of unselected adults presenting to 
the ED at the Health Sciences Centre Hospital (Winnipeg, Manitoba) 
was performed. Study procedures included pre- and post-test counsel-
ling, administration of the INSTI HIV-1/HIV-2 Antibody Test 
(bioLytical Laboratories, Canada) and a brief questionnaire. Venous 
blood samples were collected from participants for confirmatory test-
ing on all reactive and indeterminate specimens. 
resuLTs: In total, 501 adults participated in the study. The majority 
of participants were younger than 40 years of age, approximately one-
half (48.5%) were women and 53% self-identified as Aboriginal. 
Nearly one-half (49.1%) of the participants had undergone previous 
HIV testing, although 63% of these tests were performed more than a 
year earlier. A total of seven individuals tested reactive with the POC 
test, all of whom were confirmed positive using serological testing 
(1.4%) and were linked to an HIV specialist within 24 h. Nearly all of 
the participants (96%) reported satisfaction with the test and believed 
it belonged in the ED (93%).
ConCLusIons: Of the participants tested, 1.4% tested reactive for 
HIV, which is significantly higher than the reported prevalence in 
Manitoba and in other similar studies conducted in North America. 
Furthermore, all individuals were linked to timely care. The present 
study demonstrated that this particular busy tertiary care ED is an 
important and feasible location for HIV POC testing.
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La faisabilité et le succès du test de dépistage du 
VIH au point de service au sein du département 
d’urgence d’un établissement canadien en milieu 
urbain
InTroDuCTIon : Environ 26 % des Canadiens qui sont atteints du 
VIH ne connaissent pas leur statut. Les tests du VIH au point de service 
(PDS) ont créés pour simplifier et généraliser le test du VIH. 
oBJeCTIF : Évaluer la faisabilité et l’acceptabilité du test au PDS au sein 
d’une urgence de Winnipeg, au Manitoba.
MÉTHoDoLogIe : Les chercheurs ont procédé à une étude transversale 
auprès d’adultes non sélectionnés qui se sont présentés à l’urgence du 
Health Sciences Centre Hospital de Winnipeg, au Manitoba. Pendant 
l’étude, les interventions incluaient des conseils avant et après le test, 
l’administration du test INSTI de recherche des anticorps anti-VIH-1/
VIH-2 (bioLytical Laboratories, Canada) et un bref questionnaire. Ils ont 
prélevé du sang veineux pour effectuer un test de confirmation sur tous les 
échantillons réactifs ou indéterminés.
rÉsuLTaTs : Au total, 501 adultes ont participé à l’étude. La majorité 
avaient moins de 40 ans, environ la moitié (48,5 %) étaient des femmes et 
53 % ont eux-mêmes précisé qu’ils étaient des Autochtones. Près de la 
moitié (49 %) avaient déjà subi un test du VIH, mais 63 % de ces tests 
avaient été exécutés plus d’un an auparavant. Au total, sept personnes 
étaient réactives au test au PDS, toutes confirmées comme positives au test 
sérologique (1,4 %) et ont été orientées vers un spécialiste du VIH dans les 
24 heures. Presque tous les participants (96 %) se sont dits satisfaits du test 
et pensaient qu’il était caractéristique de l’urgence (93 %).
ConCLusIons : Sur les participants qui ont subi le dépistage, 1,4 % 
était réactif au VIH, ce qui est considérablement plus élevé que la 
prévalence déclarée au Manitoba et dans d’autres études similaires 
d’Amérique du Nord. De plus, toutes les personnes ont été orientées 
rapidement vers des soins. La présente étude a démontré que cette urgence 
de soins tertiaires achalandée est un lieu important et faisable comme PDS 
pour effectuer le test du VIH.
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Currently, there are approximately 65,000 Canadians living with HIV, and many new infections occur every year. It was estimated 
that in 2008, 2300 to 4300 new infections occurred in Canada, yet 
26% of Canadians living with HIV are unaware of their status (1). In 
2000, The Centers for Disease Control and Prevention in the United 
States (Atlanta, Georgia) estimated that 31% of persons accessing 
health care within the public sector system who tested HIV positive 
did not return to receive their results (2).
The prairie provinces of Canada are witnessing growing numbers 
of HIV-positive persons in care. The Manitoba HIV Program (MHP), 
which provides medical care to the majority (95%) of HIV-positive 
patients in Manitoba, reported 102 new cases to care in 2010. Of 
these, 35% presented late to care with CD4 counts <200 cells/mL 
(3). In untreated individuals, when the CD4 count is <200 cells/mL 
the risk of opportunistic infections significantly increases. There is 
increasing evidence that the longer antiretroviral therapy is delayed, 
the poorer the patient outcome will be, with a decreased likelihood 
of immune recovery and life expectancy (4,5). As such, current treat-
ment guidelines have shifted to recommend initiation of antiretroviral 
therapy for persons with a CD4 count between 350 cells/mL and 
500 cells/mL (6). In addition to these individual consequences of late 
presentation and delayed access to care, there are public health and 
health system implications as a reuslt of the increased cost associated 
with late presentation.
To reduce barriers to early diagnosis and increase access to timely 
care, simplified point-of-care (POC) rapid HIV tests have been intro-
duced. In October 2005, Health Canada licensed a rapid HIV test, the 
INSTI HIV-1/HIV-2 Antibody Test (bioLytical Laboratories, Canada), 
for use by health care providers in the POC setting (7). In 2006, The 
Centers for Disease Control and Prevention indicated that all individ-
uals 13 to 64 years of age should undergo routine HIV testing (8). 
Although current testing rates in Manitoba are increasing, only 6% of 
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Manitobans 16 years of age and older were tested for HIV in 2010 (3). 
Recently, in Canada, two provinces have developed guidelines to 
implement HIV POC testing (9,10), although, to date, POC testing 
has not been widely implemented.
Routine emergency department (ED) screening in high-volume 
and high-prevalence settings (≥1%) has been recommended by the 
Society for Academic Emergency Medicine Public Health and 
Education Task Force (11). EDs often serve as a primary source of care 
for a large proportion of people believed to be at risk for HIV infec-
tion. Furthermore, it is believed that EDs are one of the most com-
mon sites for missed opportunities for diagnosing HIV (12). The need 
for higher rates of HIV testing in Manitoba remains unmet and rapid 
HIV POC testing in the ED setting presents an opportunity to offer 
testing to individuals who might otherwise not be tested. The present 
article described the results of a study evaluating the feasibility and 
acceptability of HIV POC testing in a Manitoba ED setting.
MeTHoDs
study design
A cross-sectional study of unselected adults presenting to the ED at 
the Health Sciences Centre (HSC) Hospital in Winnipeg (Manitoba) 
between October 2010 and September 2011 was conducted.
study setting and population
The HSC Hospital is the major urban tertiary care hospital in Winnipeg 
and serves a large, underprivileged population of low socioeconomic 
status, who often have limited access to primary care. At the HSC 
Hosptial ED, there are approximately 27,000 visits per year from persons 
in the highest-risk age group (ie, 17 to 44 years of age) for HIV, which 
represents a large number of individuals for HIV screening.
All patients 18 years of age and older who presented to the HSC 
Hospital ED were eligible to participate in the study. Patients who self-
identified as HIV positive or who had altered mental status and were, 
therefore, deemed unable to provide consent, were excluded.
Data collection
ED staff, including both doctors and nurses, informed eligible ED 
patients of the study and, if patients indicated interest in learning 
more, they were approached by a research nurse trained in HIV testing 
and counselling. Following informed consent, pretest counselling was 
conducted, followed by administration of the INSTI HIV-1/HIV-2 
Antibody Test at the bedside. Post-test counselling was subsequently 
conducted during the same visit and a brief questionnaire was com-
pleted, which collected basic sociodemographic information, the rea-
son for the ED visit and HIV-related risk behaviours. Pre- and post-test 
counselling included teaching the participant about HIV, transmission 
modes, risk reductions, time frames for positivity after exposure and 
post-test follow-up, as required. Participants were also asked questions 
to assess their level of satisfaction, using a 5-point Likert scale, with 
the ED POC test (POCT), including their confidence in the test result 
and willingness to undergo future POC testing.
Fingerprick blood samples were collected for POC testing. A venous 
blood sample was collected from participants who had reactive and 
indeterminate specimens and were sent to the Cadham Provincial 
Laboratory (Winnipeg, Manitoba) for confirmatory enzyme immuno-
assay and western blot testing.
The present study was conducted between October 2010 and 
September 2011. Recruitment initially began in the triage area of the 
ED, but due to service volume constraints, this process changed and 
the majority of the participants were recruited in the minor treatment 
area of the ED. Recruitment occured Monday through Friday between 
08:00 and 17:00.
statistical analysis
Data were entered into Access (Microsoft Corporation, USA) and sta-
tistical analysis was performed using STATA version 9.2 (StataCorp, 
USA). Risk groups were assigned to participant records by applying 
the Public Health Agency of Canada’s risk hierarchy (13) to risk 
behaviours reported on questionnaires. Descriptive statistics using 
measures of central tendencies were reported. An exact binomial 
95% CI was calculated for every estimate using a Clopper-Pearson 
interval. Pearson χ2 tests were used to test for associations between 
having undergone a previous HIV test and sociodemographic char-
acteristics, HIV-risk category, reason for ED attendance and test 
result.
ethical considerations
Ethics approval was obtained from the Health Research Ethics Board 
of the University of Manitoba (Winnipeg, Manitoba).
resuLTs
The characteristics of the 501 study participants are presented in 
Table 1. Of the 501 participants, 55 (11.0%) completed HIV POC 
testing but did not complete the post-test questionnaire assessing satis-
faction. The primary reasons for noncompletion of the questionnaire 
included refusal and lack of time due to conflicting ED care. The 
majority of participants were younger than 40 years of age and approxi-
mately one-half (48.5%) were women, and 53% of the participants 
self-identified as Aboriginal, including First Nations, Inuit and Metis. 
Heterosexual sex was the most commonly reported risk factor for 
transmission. However, a substantial proportion reported no risk fac-
tor, or being married or in a monogamous relationship.
Nearly one-half (49.1%) of the participants had undergone a previ-
ous HIV test, although 63% of these tests were performed more than a 
year earlier; testing profiles are shown in Table 2. Women were signifi-
cantly more likely to have undergone a previous HIV test, and higher 
rates of testing were also apparent among injection drug users and men 
who have sex with men. Individuals who reported no risk or being mar-
ried or in a monogamous relationship were significantly less likely to 
have had a previous HIV test. Almost 40% of individuals did not have a 
family doctor but this had no significant association with whether they 
had received an HIV test previously.
A total of seven persons (1.4%) tested reactive using the POCT, 
and all were confirmed positive using standard serological testing. 
The characteristics of participants who tested positive are shown in 
Table 3. The median age of the individuals who tested positive was 
44 years (mean [±SD] age 43.3±14.6 years). Of the seven individuals, 
five were men, four self-identified as Aboriginal, five had a regular 
family doctor and six had been seen by a doctor in the previous year. 
Of the seven individuals who had tested positive, six had previously 
had an HIV test, but the majority of these tests (n=4) were con-
ducted more than a year earlier. Three individuals who had tested 
positive had CD4 counts >350 cells/mL and presented to the ED 
with non-HIV associated complaints (data not shown), and the 
remaing four individuals had CD4 counts <200 cells/mL and pre-
sented with HIV-associated opportunistic infections including 
Pneumocystis pneumonia, Candida esophagitis and cryptococcal men-
ingitis (data not shown). Within 24 h of the reactive test result, all 
seven individuals were linked with an HIV specialist and a program 
team for ongoing care. Four of the seven individuals were admitted 
to hospital for their presenting condition and were followed by the 
HIV team during their admission. These four individuals were seen 
in the HIV outpatient clinic within two weeks of their discharge 
from hospital. Two of the three individuals who were not admitted to 
hospital were seen in the HIV outpatient clinic within 10 days of 
their diagnosis. The third individual has been in contact by tele-
phone with the HIV team but has not yet attended an outpatient 
appointment.
Nearly all (96%) of the participants reported satisfaction with the 
test and 95.5% of participants were confident of the accuracy of the 
test. Furthermore, almost all of the participants believed the test 
belonged in the ED (93%) and indicated that if they had the opportun-
ity they would retest with POCT in the future (96%). Overall, persons 
testing positive for HIV reported similar levels of satisfaction.
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DIsCussIon
Among participants in the present study, the HIV-positivity rate (1.4%) 
was relatively high compared with the overall estimated HIV incidence 
in Manitoba of seven cases per 100,000 population (14) and the estimated 
Canadian HIV prevalence of <0.5% (1). Furthermore, the proportion of 
HIV-positive individuals in the present study was substantially higher 
than similar studies conducted in other EDs. A recent review, which 
examined 11 studies evaluating nontargeted HIV screening in EDs, 
reported an overall prevalence of 0.52% (12). Given the high prevalence 
among participants in the present study, the results suggest that the ED is 
an important location for rapid POC HIV testing in Manitoba.
Of additional importance was that the present study, through its 
nontargeted approach, facilitated access to testing for individuals 
who may not have otherwise been tested for HIV. A large proportion 
of participants did not identify themselves as being at risk for HIV 
infection. This was reflected in their testing history; individuals who 
indicated that they were married or in a monogamous relationship 
were significantly less likely to have undergone an HIV test. In addi-
tion, three of the seven individuals who tested positive had CD4 
counts >350 cells/mL and presented for conditions unrelated to their 
HIV, suggesting that they may not have otherwise been tested if only 
risk-based screening was applied.
Furthermore, it is of tremendous significance that all the individ-
uals who tested positive in our study were linked to timely care. Many 
argue that HIV screening alone is insufficient and that linkage to care 
should be considered as a more relevant marker (15). The present 
study demonstrated not only a high case detection rate, but also the 
ability to link all new cases of HIV to care within a short period of 
time, which has the potential to improve individual health outcomes.
The present study had several limitations. A convenience sampling 
of adults presenting to the ED was used and, as a result, may not be 
entirely representative of the entire population of Manitoba. In addi-
tion, the present analysis was a single-institution study; participants 
were only recruited from the HSC Hospital ED. We did not collect 
information on individuals who declined to participate in the study 
and, therefore, could not define how their sociodemographic character-
istics may have differed from the study population. Furthermore, we 
could not determine the HIV prevalence of individuals who declined to 
participate in the study. There is some evidence to suggest that the rate 
of occult HIV infection is higher in individuals who decline routine ED 
HIV testing (16). Although considerable training was conducted with 
the ED staff regarding the eligibility criteria and the nontargeted 
design, there may have been some selection bias by the ED staff in 
screening potential participants. However, participants were recruited 
TaBle 1
Profile of study participants
Characteristic
n (%)  
(total sample size = 501)
Age*, years   
   18 to 24 104 (20.8)
   25 to 29 57 (11.4)
   30 to 34 59 (11.8)
   35 to 39 54 (10.8)
   40 to 44 58 (11.6)
   45 to 49 51 (10.2)
   50 to 54 52 (10.4)
   ≥55 65 (13.0)
Sex   
   Female 243 (48.5)
   Male 257 (51.3)
   Other 1 (0.2)
Ethnicity   
   Aboriginal 264 (52.7)
   Caucasian 199 (39.7)
   Other 38 (7.6)
Community of residence*   
   Outside of Winnipeg, Manitoba 83 (16.6)
   Winnipeg 417 (83.2)
Has family doctor   
   No/don’t know 187 (37.3)
   Yes 314 (62.7)
Has seen doctor in the past year   
   No/don’t know 26 (5.2)
   Yes 475 (94.8)
HIV risk category   
   Heterosexual 252 (50.3)
   Married/monogamous 64 (12.7)
   Injection drug use 39 (7.7)
   Men who have sex with men 9 (1.8)
   No identifiable risk 114 (22.7)
   Occupational/blood and blood products 6 (1.4)
   Other 17 (3.4)
*n=500
TaBle 2
Characteristics of participants with previous HIV tests
 
Characteristic
Previous HIV test, n (%)
PNo/don’t know Yes
Age, years    
   18 to 24 55 (22.3) 49 (19.3) 0.002
   25 to 29 27 (10.9) 30 (11.8)  
   30 to 34 19 (7.7) 40 (15.7)  
   35 to 39 19 (7.7) 35 (13.8)  
   40 to 44 31 (12.6) 27 (10.6)  
   45 to 49 26 (10.5) 25 (9.8)  
   50 to 54 25 (10.1) 27 (10.6)
   ≥55 45 (18.2) 20 (7.9)
Sex    
   Female 92 (37.4) 151 (59.4) <0.001
   Male 154 (62.6) 103 (40.6)  
Ethnicity    
   Aboriginal 115 (46.6) 149 (58.7) 0.0252
   Caucasian 111 (44.9) 88 (34.6)  
   Other 21 (8.5) 17 (6.7)  
Place of residence    
   Outside of Winnipeg, 
      Manitoba
45 (18.2) 38 (15.0) 0.3365
   Winnipeg 202 (81.8) 215 (84.6)  
Has family doctor    
   No/don’t know 96 (38.9) 91 (35.8) 0.4819
   Yes 151 (61.1) 163 (64.2)  
Has seen doctor in the past year   
   No/don’t know 14 (5.7) 12 (4.7) 0.634
   Yes 233 (94.3) 242 (95.3)  
Risk factor(s)    
   Heterosexual 119 (47.9) 133 (52.6) <0.001
   Injection drug use 9 (3.6) 30 (11.9)  
   MSM 2 (0.8) 7 (2.8)  
   Married/monogamous 45 (18.2) 19 (7.5)
   No identifiable risk 64 (25.8) 50 (19.8)  
   Occupational/BBP 3 (1.2) 3 (1.2)  
   Other 6 (2.4) 11 (4.4)  
BBP Blood and blood products; MSM Men who have sex with men; NIR No 
identifiable risk 
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throughout the week and at different times of the day and, therefore, 
we believe we captured a reasonable representation of the population 
attending the HSC Hospital ED. In fact, it is possible that the positivity 
rate may have been even higher if study nurses were available during 
nights and on weekends.
There is growing recognition of the need to increase testing and to 
facilitate earlier diagnosis and linkage to care, given the challenges 
associated with late presentation, as outlined below. First, in terms of 
public health considerations, the longer patients are unaware of their 
HIV infection, or have untreated infection, the more opportunities 
there are for transmission. There has been considerable interest in the 
use of antiretroviral treatment for prevention of HIV by reducing viral 
load (17-20). In a recent clinical trial, early treatment resulted in a 
96% relative reduction in sexual transmission of HIV among serodis-
cordant couples (21). Second, health care costs are inversely related to 
CD4 cell counts. The annual cost for a patient with a CD4 count 
<200 cells/mL is approximately twice that of a patient whose counts 
are >500 cells/mL (22). A Canadian study conservatively estimated 
that the annual excess cost due to late presentation of HIV was $9,723 
per case (22) and, more recently, it was demonstrated that significantly 
higher costs are incurred for those presenting to care with CD4 counts 
<350 cells/mL compared with individuals with higher CD4 counts, 
and that these higher costs were sustained beyond the first year of care 
for those individuals (23). Finally, late presentation is known to 
increase the risk of HIV-related complications and reduce life expect-
ancy (24,25). Life expectancy is strongly correlated with CD4 count at 
the start of therapy (26).
As such, it is important to expand testing options, including ensuring 
that HIV testing is offered in settings where high-risk individuals are likely 
to be seen (27). It is recognized that the ED is a primary place of care for 
persons with limited access to health care (28), low income populations 
(15) and individuals believed to be at high risk for HIV infection (29). As 
such, the ED has been recognized as an important setting for HIV testing, 
yet, despite this, HIV screening in the ED has not been systematically 
implemented in Canada. We believe the present study demonstrates the 
success and feasibility of conducting HIV POC testing in a busy tertiary 
care ED in Winnipeg. As other testing options, such as home-based HIV 
testing kits that have recently been approved by the United States Food 
and Drug Administration (30), become available in Canada, they will also 
need to be evaluated and offered as appropriate.
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TaBle 3
Characteristics of participants with positive HIV test results
Characteristic n (%)   
Age, years   
   18 to 24 1 (14.3)
   30 to 34 2 (28.6)
   40 to 44 1 (14.3)
   45 to 49 1 (14.3)
   ≥55 2 (28.6)
Sex   
   Female 2 (28.6)
   Male 5 (71.4)
Ethnicity   
   Aboriginal 4 (57.1)
   Caucasian 3 (42.9)
Community of residence   
   Outside of Winnipeg, Manitoba 1 (14.3)
   Winnipeg 6 (85.7)
Has family doctor   
   No/don’t know 2 (28.6)
   Yes 5 (71.4)
Has seen doctor in the past year   
   No/don’t know 1 (14.3)
   Yes 6 (85.7)
HIV risk category   
   Heterosexual 2 (28.6)
   Injection drug use 1 (14.3)
   Men who have sex with men 3 (42.9)
   Other 1 (14.3)
Year of last HIV test   
   2010/2011 2 (28.6)
   Before 2010 4 (57.1)
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